GE HealthCare Launches AI-Driven Invenia ABUS Premium for Dense Breast Screening

GE HealthCare has introduced the Invenia Automated Breast Ultrasound (ABUS) Premium, an AI-powered 3D ultrasound system designed to enhance breast cancer detection in dense breast tissue while accelerating scan times.

Key Features:

• AI Integration: Includes Verisound AI and AI Assistant for faster, more consistent scanning and reading.
• Enhanced Imaging: The cSound Imageformer ensures high-resolution, consistent images.
• Faster Scanning: The Fast Scan tool reduces scan time by up to 40%.
• Improved Accuracy: Features like Scan Quality Assessment and Auto Nipple Detection ensure proper breast coverage.
• Better Diagnosis Support: AI algorithms assist in lesion detection and characterization, reducing unnecessary biopsies and allowing earlier treatment escalation.
• Patient Comfort & Safety: The Reverse Curve transducer and custom compression levels improve exam experience while eliminating radiation exposure.

This FDA-approved technology will launch in key global markets, reinforcing GE HealthCare's commitment to early cancer detection and autonomous imaging solutions.

22-03-2025

• Pharma GMP
• Food GMP
• Clinical Research
• Medical Device
• Environmental Health and Safety
• Healthcare
• Nutrition